The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.103_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Diffuse Large B-Cell Lymphoma Transformed From MALT Lymphoma Presented by Acute Abdomen

Bezmialem Science
2015English

Diffuse Large B-Cell Lymphoma

2020English

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

A Multicentre Study of Primary Breast Diffuse Large B-Cell Lymphoma in the Rituximab Era

British Journal of Haematology
Hematology
2014English

Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis

Current Biomarker Findings
BiochemistryClinical Biochemistry
2013English

Secondary Cutaneous Diffuse Large B-Cell Lymphoma Has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-Cell Lymphoma, Leg Type

Acta Dermato-Venereologica
DermatologyMedicine
2016English

Is Radiotherapy Still Necessary for Diffuse Large B-Cell Lymphoma Therapy?

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2015English

The Kyoto Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy